Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inflammatory Response
Open-data reference.
17 US clinical trials · 5 currently recruiting
Active & Recent Trials
Social Experiences and Demographic Factors in the Regulation of Immune Cells
Morgan State University
NCT06519487
Daoist Zhanzhuang and Human Flourishing
University of North Carolina, Charlotte
NCT06573034
Menthol, Inflammation, and Nicotine Transition Study
Rosalind Franklin University of Medicine and Science
NCT06232447
Association Between Body Composition and Pain in Spinal Cord Injury
University of Miami
NCT05459207
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
University of Southern California
NCT05934708
Pistachio Consumption on Inflammatory Markers and Lean Body Mass
Virginia Polytechnic Institute and State University
NCT06342024
Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human
Clinical Nutrition Research Center, Illinois Institute of Technology
NCT04267705
Sleep and Inflammatory Resolution Pathway
Beth Israel Deaconess Medical Center
NCT03377543
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
University of Connecticut
NCT06086795
Beef and Plant Burger Metabolomics Study
Utah State University
NCT05690061
The Effects of Agro-ecological Farming Systems on Human Health
Utah State University
NCT05575258
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
Kevin Hill
NCT03229538
Persistent Readiness Through Early Prediction Immunization Study
Texas A&M University
NCT05346302
Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults
Formula30A
NCT05743985
Inhibition of Sterile Inflammation by Digoxin
Yale University
NCT03559868
Cranberry Ingestion and Cycling Related Immunity and Inflammation
Appalachian State University
NCT05407701
The Effect of Chiropractic Plus Nutritional Supplement in Patients With Chronic Pain and Inflammation.
Standard Process
NCT05743855
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 3 |
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Inflammatory Response Trial Landscape
ClinicalTrials.gov lists 17 US studies indexed under Inflammatory Response, and 5 of those are currently open to recruitment — roughly 29% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Inflammatory Response shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Inflammatory Response is led by Utah State University with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 17 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Inflammatory Response?
PlainTrial tracks 17 US clinical trials for Inflammatory Response, of which 5 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Inflammatory Response?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.